The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative
The global medical device clinical trials market is experiencing remarkable growth, with forecasts predicting an upward trajectory from USD 16.70 billion in 2024 to USD 30.53 billion by 2034. This substantial increase is largely driven by the pervasive rise in chronic diseases, which sets the stage
INCOG, a contract development and manufacturing organization (CDMO), recently made a substantial investment to expand its capabilities in the sterile injectables sector. In February 2024, the company committed $75 million to install an Optima syringe and cartridge filling line, projected to be GMP
The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as regulatory
The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,
Artis Biosolutions' acquisition of Landmark Bio marks a strategic move designed to bolster cell and gene therapy (CGT) manufacturing capabilities. Landmark Bio, founded by Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Alexandria Real Estate Equities, and Cytiva, has been a key player
